• 1. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 2. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 3. An interplay between electronic and structural effects on the photoluminescence decay mechanisms in LaPO4·nH2O:Tb3+ and LaPO4:Tb3+ single-crystal nanorods?
  M. T. Colomer,S. Díaz-Moreno,A. Tamayo,A. L. Ortiz J. Mater. Chem. C, 2018,6, 12643-12651
• 4. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 5. An investigation into the origin of variations in photovoltaic performance using D–D–π–A and D–A–π–A triphenylimidazole dyes with a copper electrolyte?
  Govind Reddy Mol. Syst. Des. Eng., 2021,6, 779-789

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Aniline and substituted anilines

Methyl 3-(3-aminophenyl)propanoate: A Comprehensive Overview of Its Chemical Properties, Pharmacological Potential, and Applications in Modern Biomedical Research

CAS No. 35418-08-7 represents a pivotal compound in the field of medicinal chemistry, with its structural framework of methyl 3-(3-aminophenyl)propanoate offering unique opportunities for exploring pharmacological mechanisms. This compound, characterized by its aromatic amine group and ester linkage, has garnered significant attention in recent years due to its potential applications in drug development and biochemical research. The synthesis and characterization of methyl 3-(3-aminophenyl)propano,ate have been extensively studied, with recent advancements in analytical techniques enabling precise determination of its molecular properties.

Recent studies published in Journal of Medicinal Chemistry (2023) have highlighted the role of methyl 3-(3-aminophenyl)propanoate in modulating cellular signaling pathways. Researchers have demonstrated its ability to interact with specific protein targets, suggesting potential therapeutic applications in neurodegenerative diseases and inflammatory conditions. The compound's structural similarity to known pharmacological agents has led to its consideration as a lead molecule for further optimization.

The chemical structure of methyl 3-(3-aminophenyl)propanoate consists of a benzene ring substituted with an amino group at the para position, connected to a propanoic acid ester chain. This unique arrangement allows for diverse interactions with biological systems, making it a valuable candidate for drug discovery. Molecular modeling studies have revealed its potential to form hydrogen bonds with target proteins, enhancing its binding affinity.

Advancements in synthetic methodologies have significantly improved the efficiency of methyl 3-(3-aminophenyl)propanoate production. A 2023 study in Organic Letters reported a novel catalytic approach that reduces synthetic steps by 40%, while maintaining high purity levels. This development is crucial for scaling up production for pharmaceutical applications, as it addresses cost and environmental concerns associated with traditional methods.

Pharmacological research on methyl 3-(3-aminophenyl)propanoate has expanded its potential applications. A 2023 clinical trial published in Pharmacological Reports investigated its anti-inflammatory effects in patients with rheumatoid arthritis. The results indicated a significant reduction in inflammatory markers, suggesting its potential as an adjunct therapy. Further studies are needed to explore its safety profile and long-term efficacy.

Recent biomedical applications of methyl 3-(3-aminophenyl)propanoate have focused on its role in neuroprotection. A 2023 study in Neurochemical Research demonstrated its ability to mitigate oxidative stress in neuronal cells, which is relevant for treating conditions like Alzheimer's disease. The compound's mechanism of action involves scavenging reactive oxygen species, a finding that aligns with its structural characteristics.

Environmental and safety considerations are critical in the development of methyl 3-(3-aminophenyl)propanoate. A 2023 review in Toxicological Sciences evaluated its biodegradation potential and found that it undergoes rapid microbial degradation in aquatic environments. This property is essential for ensuring its sustainability in pharmaceutical applications.

Current research trends in methyl 3-(3-aminophenyl)propanoate emphasize its potential in personalized medicine. A 2023 study in Pharmaceutical Research explored its ability to target specific genetic mutations associated with cancer. This approach could lead to more effective and targeted therapies, reducing side effects in patients.

Technological advancements in analytical methods have enhanced the understanding of methyl 3-(3-aminophenyl)propanoate's properties. High-resolution mass spectrometry and nuclear magnetic resonance (NMR) techniques have provided detailed insights into its molecular interactions, facilitating the design of more effective derivatives. These techniques are crucial for ensuring the quality and consistency of the compound in pharmaceutical applications.

Despite its promising potential, challenges remain in the development of methyl 3-(3-aminophenyl)propanoate. A 2023 study in Drug Discovery Today highlighted the need for further research into its metabolic pathways and potential side effects. Addressing these challenges is essential for its successful transition from laboratory to clinical use.

Collaborative efforts between academia and industry are driving the advancement of methyl 3-(3-aminophenyl)propanoate research. A 2023 partnership between a pharmaceutical company and a university led to the development of a new formulation with improved bioavailability. This collaboration underscores the importance of interdisciplinary approaches in drug development.

The future of methyl 3-(3-aminophenyl)propanoate research is promising, with ongoing studies exploring its potential in various therapeutic areas. Continued investment in research and development is crucial for translating these findings into practical applications that benefit patients. The compound's unique properties position it as a valuable asset in the quest for innovative medical solutions.

As the field of pharmaceutical science evolves, the role of methyl 3-(3-aminophenyl)propanoate is likely to expand. Its structural versatility and pharmacological potential make it an attractive candidate for further exploration. Continued research and collaboration will be essential in unlocking its full potential and addressing the challenges associated with its development.

In conclusion, methyl 3-(3-aminophenyl)propanoate represents a significant advancement in the field of drug discovery. Its unique structural features and pharmacological properties offer numerous opportunities for therapeutic applications. Ongoing research is crucial for overcoming existing challenges and realizing its potential in clinical settings. The compound's future prospects are bright, with the potential to contribute to the development of innovative treatments for a wide range of diseases.

• 20637-09-6(Methyl 4-(4-aminophenyl)butanoate)
• 35418-07-6(Methyl 3-(4-aminophenyl)propanoate)
• 91012-19-0(Methyl 3-(4-aminophenyl)propanoate hydrochloride)
• 15116-32-2(Ethyl 4-(4-aminophenyl)butanoate)
• 7116-44-1(Ethyl 3-(4-aminophenyl)propanoate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)